Growth & Returns

With 500,000 voters at risk of being silenced, Élections Québec is overhauling its process. Here's how they're making every vote count in 2026.

While a local Indiana story highlights the human cost of caregiver burnout, it unveils a massive, underserved market poised for explosive growth and fintech innovation.

New data reveals elevated cortisol in over 75% of hard-to-treat diabetes patients, paving the way for a novel drug to tackle treatment resistance.

A small Houston firm's modular waste-to-methanol plant in Porto is more than a green project; it's a strategic blueprint for European energy sovereignty.

Legend Biotech's stunning trial results for an 'in vivo' CAR-T therapy could make advanced cancer treatment faster, safer, and accessible to all.

Clip Money extends its debt runway, but a split among investors reveals a deeper story. Is this a savvy move to fuel expansion or a necessary patch on a leaky hull?

With CEO Reedy's sudden retirement, aerospace innovator Butler National enters a critical transition. We explore his legacy and what's next for the tech firm.

A new, single-shot vaccine for dogs targets two spreading diseases. This innovation aims to make vet visits less stressful and close critical health gaps.

The fast-food giant is refinancing its debt at a much higher interest rate. Is this a savvy move to optimize its balance sheet or a costly sign of trouble?

Amid new Ebola fears, one biotech's rapid C1 platform promises 15-day biologics, eyeing a $25B market beyond just pandemic response. But can it deliver?

The collateral management firm appoints a new CPO and promotes key execs, signaling a foundational shift to build autonomous AI-native products.

With the 2026 World Cup looming, Men in Blazers partners with NFQ Technologies to build a central digital hub, aiming to turn fleeting attention into lasting loyalty.

Beyond the hype, a new report reveals a 4.8% CAGR for sports merchandise. The real story is the operational pivot to digital-first supply chains.

A landmark deal between IQE and Tower Semiconductor not only ends a bitter IP dispute but also secures a vital supply line for the optical chips powering the AI revolution.

While Nevada's cannabis market contracts, C21 Investments posts record customer growth and an 8% revenue jump, fueled by a high-stakes tax challenge.

With a high-yield dividend and perfect rent collection, NewLake Capital signals stability. But is this cannabis REIT a safe haven or just a high-risk reward?

A new app promises 'pure adrenaline' by turning every moment of a soccer match into a game. But is it harmless fun or a gateway to the next frontier of gambling?

How one imaging company is challenging sports photography norms by investing in the creator economy and the powerful stories hidden beyond the final score.

A local bank awarded 10 scholarships from 340+ applicants. It's not just goodwill; it's a strategic investment in human capital addressing a critical gap.

As Xtract One woos investors in Vegas, its AI security tech promises safety without sacrificing freedom. But can it scale its vision of a frictionless world?